Within the down-regulated genes were genes associated with increased proliferation in prostate cancer including KLK2, PCAT-1 and VAV3. KLK2 is a known activator of PSA, which is an important biomarker of prostate cancer, and associated with decreased apoptosis [77, 84]. This evidence concerns the gene KLK2 and prostate carcinoma.